COMPARISON OF MONOTHERAPY WITH A LONG-ACTING MUSCARINIC ANTAGONIST VERSUS COMBINATION THERAPY WITH A LONG-ACTING MUSCARINIC ANTAGONIST PLUS A LONG-ACTING BETA2-AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

被引：0
|
作者：
Yosuke, Tanaka [1 ]
Mitsunori, Hino [1 ]
Naomi, Onda [1 ]
Hiroyuki, Takoi [1 ]
Seiji, Kosaihira [1 ]
Norihisa, Motohashi [1 ]
Akihiko, Gemma [1 ]
机构：
[1] Chiba Hokusoh Hosp, Resp Dis Ctr, Nippon Med Sch, Chiba, Japan
来源：
RESPIROLOGY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P-F-073
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [21] Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease
    Karner, Charlotta
    Cates, Christopher J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [22] COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Iwasaki, Kentarou
    Kojika, Masakazu
    Hayashi, Aeru
    RESPIROLOGY, 2018, 23 : 247 - 247
  • [23] CAPTAIN: Effects of Adding the Long-Acting Muscarinic Antagonist Umeclidinium to Inhaled Corticosteroid/Long-Acting Beta2-Agonist Therapy on Symptoms in Patients with Inadequately Controlled Asthma
    Gardiner, F.
    Pizzichini, E.
    Pavord, I
    Brusselle, G.
    Oppenheimer, J.
    Kerstjens, H.
    Papi, A.
    Inoue, H.
    Tabberer, M.
    Fowler, A.
    Slade, D.
    Bailes, Z.
    Barnes, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [24] Issues on Safety of Long-Acting Muscarinic Antagonist
    Lee, Yang Deok
    Cho, Yongseon
    Han, Min Soo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2011, 70 (05) : 384 - 389
  • [25] Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease
    van Geffen, Wouter H.
    Tan, Daniel J.
    Walters, Julia A. E.
    Walters, E. Haydn
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (12):
  • [26] Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease
    Tan, Daniel J.
    White, Clinton J.
    Walters, Julia A. E.
    Walters, E. Haydn
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (11):
  • [27] Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β2-agonist bronchodilators
    Skolnik, Neil S.
    Nguyen, Trang Susan
    Shrestha, Aarisha
    Ray, Riju
    Corbridge, Thomas C.
    Brunton, Stephen A.
    POSTGRADUATE MEDICINE, 2020, 132 (02) : 198 - 205
  • [28] Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
    Oba, Yuji
    Chandran, Arul V.
    Devasahayam, Joe V.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (06) : 677 - 685
  • [29] Efficacy and Safety of Long-Acting β-Agonist/Long-Acting Muscarinic Antagonist Combinations Compare to Long-Acting β-Agonist/Inhaled Corticosteroid Combinations: A Network Meta-Analysis
    Ahmed, T. Said
    Al-Sarie, M.
    Srour, K.
    Rygielski, S.
    Ye, F.
    Hernandez, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [30] Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonists for chronic obstructive pulmonary disease
    Javier Nannini, Luis
    Lasserson, Toby J.
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
12345